The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for irinotecan (as sucrosofate) (Servier Laboratories (Aust) Pty Ltd)
Active ingredients
irinotecan (as sucrosofate)
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Concentrated Injection
Indication
First-line treatment of adult patients with metastatic adenocarcinoma of the pancreas, in combination with oxaliplatin, 5 fluorouracil (5 FU) and leucovorin (LV)
Therapeutic area
Oncology